Fungal keratitis

Current Opinion in Ophthalmology

Volumn 15, Issue 4, 2004, Pages 321-327

  Srinivasan, M ^a  

^a ARAVIND EYE CARE SYSTEM   (India)

Author keywords

Antimycotic drugs; Fungal keratitis; Keratomycosis; Mycotic keratitis; Voriconazole

Indexed keywords

AMPHOTERICIN B; AMPHOTERICIN B DEOXYCHOLATE; ANTIFUNGAL AGENT; CLOTRIMAZOLE; ECHINOCANDIN B; FLUCONAZOLE; IMIDAZOLE DERIVATIVE; KETOCONAZOLE; MICONAZOLE; NATAMYCIN; POLY(HEXAMETHYLENEBIGUANIDE); POLYETHYLENE DERIVATIVE; POVIDONE IODINE; PYRROLE DERIVATIVE; TRIAZOLE; VORICONAZOLE;

AFRICA; ANTIBIOTIC THERAPY; ASIA; ASPERGILLUS; CANDIDA; CLINICAL FEATURE; CONFOCAL MICROSCOPY; CONTACT LENS; CORNEA SURGERY; CORNEA TRANSPLANTATION; DIAGNOSTIC APPROACH ROUTE; DISEASE PREDISPOSITION; DISEASE SEVERITY; DRUG EFFICACY; DRUG INDICATION; DRUG SAFETY; DRUG TOLERABILITY; EYE INJURY; FUNGAL VIRULENCE; FUNGUS CULTURE; FUSARIUM; HUMAN; INCIDENCE; INFECTION RISK; KERATITIS; KERATOMYCOSIS; LABORATORY TEST; MYCOSIS; NONHUMAN; POLYMERASE CHAIN REACTION; POPULATION RESEARCH; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; RISK FACTOR; SIDE EFFECT; SMEAR; STEROID THERAPY; TOPICAL TREATMENT;

ADMINISTRATION, TOPICAL; CONTACT LENSES; EYE INJURIES; HUMANS; INCIDENCE; INDIA; KERATITIS; MYCOSES; STEROIDS;

EID: 3242689513     PISSN: 10408738     EISSN: None     Source Type: Journal    
DOI: 10.1097/00055735-200408000-00008     Document Type: Review

References (53)

1. Whitcher JP, Srinivasan M, Upadhyay MP: Corneal blindness: a global perspective. Bull World Health Organ 2001, 79:214-221.
2. Sharma S, Srinivasan M, George C: The current status of Fusarium species in mycotic keratitis in South India. J Med Microbiol 1993, 11:140-147.
3. Upadhyay MP, Karmacharya PC, Koirala S, et al. Epidemiologic characteristics, predisposing factors, and etiologic diagnosis of corneal ulceration in Nepal. Am J Ophthalmol 1991, 15:92-99.
4. Dunlop AA, Wright ED, Howlader SA, et al.: Suppurative corneal ulceration in Bangladesh: a study of 142 cases examining the microbiological diagnosis, clinical and epidemiological features of bacterial and fungal keratitis. Aust N Z J Ophthalmol 1994, 22:105-110.
5. Leck AK, Thomas PA, Hagan M, et al.: Aetiology of suppurative corneal ulcers in Ghana and South India, and epidemiology of fungal keratitis. Br J Ophthalmol 2002, 86:1211-1215.
6. Hagan M, Wright E, Newman M, et al.: Causes of suppurative keratitis in Ghana. Br J Ophthalmol 1995, 79:1024-1028.
7. Liesegang TJ, Forster RK: Spectrum of microbial keratitis in South Florida. Am J Ophthalmol 1980, 90:38-47.
8. Dongx: Xie L, Shi W et al. Penetrating keratoplasty in management of fungal keratitis. Chin J Ophthalmol 1994, 35:386-387.
9. Coster DJ, Wilhelmus K, Peacock J, et al.: Suppurative keratitis in London. Fourth Congress of the European Society of Ophthalmology, Royal Society of Medicine, International Congress and Symposium Series No. 40. London: 1981:395-398.
10. Asbell P, Stenson S: Ulcerative keratitis: survey of 30 years' laboratory experience. Arch Ophthalmol 1982, 100:77-80.
11. Panda A, Sharma N, Das G, et al.: Mycotic keratitis in children: epidemiologic and microbiologic evaluation. Cornea 1997, 16:295-299.
12. Bharathi MJ, Ramakrishnan R, Vasu S, et al.: Epidemiological characteristics and laboratory diagnosis of fungal keratitis: a three-year study. Indian J Ophthalmol 2003, 51:315-321. This retrospective study involved 3183 patients with corneal ulcer in a 3-year period from a single tertiary eye care center. All the data related to age, sex, risk factors, clinical features, and etiologic agents were carefully analyzed. Out of 3183 patients, 1095 (34.4%) had fungal keratitis. The Fusarium species was the principal pathogen (42.82%) Male patients were commonly affected (65%). Most of them (66.85%) were in the younger age group (21-50 years). Fungal keratitis patients had experienced ocular trauma (92%) and vegetable injury (61%). The sensitivity of KOH was 99%.
13. Srinivasan M, Gonzales CA, George C, et al.: Epidemiology and aetiological diagnosis of corneal ulceration in Madurai. South India. Br J Ophthalmol 1997, 81:965-971.
14. Tanure MA, Cohen EJ, Sudesh S, et al.: Spectrum of fungal keratitis at Wills Eye Hospital, Philadelphia, Pennsylvania. Cornea 2000, 19:307-312.
15. Cruz OA, Sabir SM, Capo H, et al.: Microbial keratitis in childhood. Ophthalmology 1993, 100:192-196.
16. Ormerod LD, Hertzmark E, Gomez DS, et al.: Epidemiology of microbial keratitis in southern California: a multivariate analysis. Ophthalmology 1987, 4:1322-1333.
17. Hoflin-Lima AL, Roizenblatt R: Therapeutic contact lens-related bilateral fungal keratitis. CLAO J 2002, 28:149-150.
18. Choi DM, Goldstein MH, Salierno A, et al.: Fungal keratitis in a daily disposable soft contact lens wearer. CLAO J 2001, 27:111-112.
19. Gopinathan U, Garg P, Fernandes M, et al.: The epidemiological features and laboratory results of fungal keratitis: a 10-year review at a referral eye care center in South India. Cornea 2002, 21:555-559.
20. Thomas PA: Current perspectives on ophthalmic mycoses. Clin Microbiol Rev 2003, 16:730-797. The author recommends natamycin as the first choice for filamentous fungal keratitis and the avoidance of corticosteroids in most ophthalmic mycoses.
21. Periman LM, Harrison DA, Kim J: Fungal keratitis after photorefractive keratectomy: delayed diagnosis and treatment in a co-managed setting. J Refract Surg 2003, 19:364-366. Reported about microbial keratitis after refractive surgery in a co-management setting. The authors highlighted the risk of misdiagnosis by co-management persons. This case illustrates some of the potential pitfalls of co-management.
22. Verma S, Tuft SJ: Fusarium solani keratitis following LASIK for myopia. Br J Ophthalmol 2002, 86:1190-1191.
23. Tuli SS, Yoo SH: Curvularia keratitis after laser in situ keratomileusis from a feline source. J Cataract Refract Surg 2003, 29:1019-1021. Authors have reported curvularia keratitis after laser in situ keratomileusis from a feline source. In this case, the cornea perforated even though no steroids were used after the diagnosis was made. The literature review stated that corneal perforation occurs five times more often in fungal keratitis than in bacterial keratitis.
24. Garg, P, Gopinathan U, Choudhary K, et al.: Keratomycosis: clinical and microbiologic experience with Dematiaceous fungi. Ophthalmology 2000, 107:574-580.
25. Chang CW, Ho CK, Chen ZC, et al.: Fungi genus and concentration in the air of onion fields and their opportunistic action related to mycotic keratitis. Arch Environ Health 2002, 57:349-354.
26. Tanure MA, Cohen EJ, Sudesh S, et al.: Spectrum of fungal keratitis at Wills Eye Hospital, Philadelphia, Pennsylvania. Cornea 2000, 19:307-312.
27. Whitcher JP, Srinivasan M: Corneal ulceration in the developing world: a silent epidemic. Br J Ophthalmol 1997, 81:622-623.
28. Thomas PA: Fungal infections of the cornea. Eye 2003, 17:852-862. This author has published several articles on fungal keratitis and has vast knowledge of the laboratory diagnosis of microbial keratitis. This article highlights the sensitivity of various stains. Gram stain will identify fungal species in 45 to 73% of cases, and Giemsa stain will identify fungi in 66%. Lactophenol cotton blue has a sensitivity of 70 to 80%. The author suggests that the current treatment regimens for mycotic keratitis need to be modified.
29. Dursun D, Fernandez V, Miller D, et al.: Advanced Fusarium keratitis progressing to endophthalmitis. Cornea 2003, 22:300-303. In a retrospective chart review of 159 Fusarium keratitis patients at Bascom Palmer Eye Institute, infection with Fusarium developed in 10 of 159 infected eyes in spite of being treated with imidazoles; natamycin 5%, and intravitreal amphotericin B.
30. Jones DB. Initial therapy of suspected microbial corneal ulcers: II. Specific antibiotic therapy based on corneal smears. Surv Ophthalmol 1979, 24:97, 105-116.
31. Forster RK, Rebell G: The diagnosis and management of keratomycoses: I. Cause and diagnosis. Arch Ophthalmol 1975, 93:975-978.
32. Sridhar MS, Sharma S, Gopinathan U, et al.: Anterior chamber tap: diagnostic and therapeutic indications in the management of ocular infections. Cornea 2002, 21:718-722.
33. Alexandrakis G, Jalali S, Gloor P: Diagnosis of Fusarium keratitis in an animal model using the polymerase chain reaction. Br J Ophthalmol 1998, 82:306-311.
34. Gaudio PA, Gopinathan U, Sangwan V, et al.: Polymerase chain reaction based detection of fungi in infected corneas. Br J Ophthalmol 2002, 86:755-760.
35. Florakis GJ, Moazami G, Schubert H, et al.: Scanning slit confocal microscopy of fungal keratitis. Arch Ophthalmol 1997, 115:1461-1463.
36. Avunduk AM, Beuerman RW, Varnell ED, et al.: Confocal microscopy of Aspergillus fumigatus keratitis. Br J Ophthalmol 2003, 87:409-410. Experimentally induced Aspergillus fumigatus keratitis in rabbits. Confocal microscopy was more sensitive than culture on days 14 and 22 in treated and untreated control rabbits.
37. O'Day DM: Selection of appropriate antifungal therapy. Cornea 1987, 6:238-245.
38. Prajna NV, John RK, Nirmalan PK, et al.: A randomised clinical trial comparing 2% econazole and 5% natamycin for the treatment of fungal keratitis. Br J Ophthalmol 2003, 87:1235-1237. Well-conducted prospective study having similar parameters about age, sex, size of ulcer, and etiologic agents. There was no statistical difference in efficacy against any of the fungi encountered in the study: 57% was Fusarium species and 67% of cases were cured.
39. O'Day DM, Head WS, Robinson RD, et al.: Corneal penetration of topical amphotericin B and natamycin. Curr Eye Res 1986, 5:877-882.
40. Mselle J: Use of topical clotrimazole in human keratomycosis. Ophthalmologica 2001, 215:357-360.
41. Meunier-Carpentier F: Treatment of mycoses in cancer patients. Am J Med 1983, 24:74-79.
42. Avunduk AM, Beuerman RW, Warnel ED, et al.: Comparison of efficacy of topical and oral fluconazole treatment in experimental Aspergillus keratitis. Curr Eye Res 2003, 26:113-117. This study investigated the therapeutic role of topical and oral fluconazole; using a rabbit model of Aspergillus fumigatus keratitis. On days 6, 10, 16, and 20 the treated groups had statistically significant lower scores compared with the untreated control groups. No significant difference was seen between the groups treated topically and orally.
43. Schreiber W, Olbrisch A, Vorwerk CK, et al.: Combined topical fluconazole and corticosteroid treatment for experimental Candida albicans keratomycosis. Invest Ophthalmol Vis Sci 2003, 44:2634-2643. The corneas of 105 rabbits in seven groups were infected with viable yeast cells of Candida albicans to determine the most efficient time point and concentration of topical corticosteroids in Candida albicans keratitis treated with fluconazole. The authors concluded that treatment with fluconazole and adjunctive high-dose prednisolone is most effective when administered 9 days after infection, and therefore steroids are not contraindicated when given with antimycotic drugs in fungal keratitis. The issue is controversial and needs more data.
44. Rao SK, Madhavan HN, Rao G, et al.: Fluconazole in filamentous fungal keratitis. Cornea 1997, 16:700.
45. Panda A, Ahuja R, Biswas NR, et al.: Role of 0.02% polyhexamethylene biguanide and 1% povidone iodine in experimental Aspergillus keratitis. Cornea 2003, 22:138-141. The authors compared the effects of natamycin, PHMB, povidone iodine and placebo in experimentally induced Aspergillus keratitits in a rabbit model and concluded the PHMB was moderately effective and 1% povidone iodine was not effective.
46. Jeu L, Piacenti FJ, Lyakhovetskiy AG, Fung HB: Voriconazole. Clin Ther 2003, 25:1321-1381. This article reviews the pharmacologic and pharmacokinetic properties and clinical usefulness of voriconazole. In head-to-head comparative trials, voriconazole appeared to be as efficacious as amphotericin B for the treatment of invasive aspergillosis. In clinical studies, it was as efficacious as fluconazole and useful against fluconazole-resistant and itraconazole- resistant strains of Candida. Dose adjustment is recommended in patients with hepatic dysfunction.
47. Shah KB, Wu TG, Wilhelmus KR, et al.: Activity of voriconazole against corneal isolates of Scedosporium apiospermum. Cornea 2003, 22:33-36. This in vitro study attempted to determine the activity of voriconazole compared with other polyene and imidazole antifungal agents against corneal isolates of Scedosporium apiospermum and found that the minimal inhibitory concentration of voriconazole was 0.5 μg/mL, a concentration lower than that of the other imidazoles.
48. Denning DW: Echinocandin antifungal drugs. Lancet 2003; 4:362:1142-1151. New antifungal drugs, echinocandins, are used for systemic mycoses. The target of echinocandins is the fungal cell wall. The antifungal spectrum is restricted to Candida species and Aspergillus, not Fusarium species.
49. Garg P, Gopinathan U, Nutheti R, et al.: Clinical experience with N-butyl cyanoacrylate tissue adhesive in fungal keratitis. Cornea 2003, 22:405-408. The use of tissue adhesive in the management of corneal thinning or perforation associated with active fungal keratitis in 73 patients in a retrospective study showed resolution infiltration with scar formation in 63% of patients.
50. Xie L, Shi W, Liu Z, Li S: Lamellar keratoplasty for the treatment of fungal keratitis. Cornea 2002, 21:33-37.
51. Panda A, Vajpayee RB, Kumar TS: Critical evaluation of therapeutic keratoplasty in cases of keratomycosis. Ann Ophthalmol 1991, 23:373-376.
52. Xie L, Dong X, Shi W: Treatment of fungal keratitis by penetrating keratoplasty. Br J Ophthalmol 2001, 85:1070-1074.
53. Yao YF, Zhang YM, Zhou P, et al.: Therapeutic penetrating keratoplasty in severe fungal keratitis using cryopreserved donor corneas. Br J Ophthalmol 2003, 87:543-547. In this retrospective consecutive case series of 45 patients with severe fungal keratitis, grafting with cryopreserved cornea seemed to have yielded excellent results, in spite of the use of topical and oral fluconazole perioperatively, in the knowledge that fluconazole is supposed to be not effective against Fusarium and Aspergillus species.